Roadmap &
Exchanges

Take a look at our journey ahead

Roadmap

Alpha 2.0 Release

100%

The latest advancements in the platform include avatars, issuing of notifications, bug-fixing throughout the platform, enterprise search functionality, an upgraded UI, and finally our blockchain transaction and verification for DNA file-uploading.

Shop 1.5 Release

100%

The release will be live to the public at 12:00 pm GMT on 23rd May.  This is a major milestone for Shivom as it will not only enable consumers to purchase directly within Shivom’s marketplace via either OMX token or fiat payment but also bring mainstream partners to Shivom’s innovative blockchain eco-system.

MVP Release

75%

This release of our platform will include full traceability on blockchain, marketplace 2.0, end-to-end data discovery and analysis solution for enterprise customers and more. The requirements we have set include that it must clearly demonstrate traceability via Ethereum blockchain and enterprise customers running complex bioinformatic pipelines against big data without leaving the platform.

Marketplace 2.0

20%

Redeem tokens for products from our direct-to-consumer partners, from kits, reports to healthcare services. The new marketplace will provide users with the ability to utilise OMX earned from research purposes to improve their health and wellbeing.

Search 2.0

75%

Search de-identified data categorised by therapeutic area, disease and/or sub-type. This will be suitably supported by filters via country, gender, pre-existing conditions etc. through phenotypic data. Along with this, our platform will provide you with the ability to save the datasets and analyse them as per your convenience.

Analysis & Reporting 1.0

25%

With an automated, 24*7 real-time analysis of DNA data, our platform offers industry standard and custom pipelines on protected datasets (GWAS, Family Trios, PWAS, etc.). The results are powered by artificial intelligence via LifeBit integration and allow for rapid response rates.

Dynamic Consent 2.0

80%

Within our dynamic consent permissioning technology data owners and custodians may choose who comes in contact with their data. For example a patient support network, government agency or pharmaceutical company.

Medical Record 1.0

40%

Medical records will be replacing our “MyDNA” page and act as a secure way to upload various medical records. From genetic data to blood tests data owners and custodians have the ability to monetise and share any type of health and or omic data with researchers.

Notifications 1.0

90%

Through the introduction of our notifications system, end-users will be able to be notified when data has been used for research purposes and when receiving compensation from smart contracts.

Smart Contracts 1.0

50%

Our first iteration of using smart contracts will provide end-users with traceability throughout user journeys (permissions, data sharing etc.)

Enterprise Dashboard 1.0

60%

Search de-identified data categorised by therapeutic area, disease and/or sub-type. This will be suitably supported by filters via country, gender, pre-existing conditions etc. through phenotypic data. Along with this, our platform will provide you with the ability to save the datasets and analyse them as per your convenience.

2FA Security

65%

With 2FA security we’ve added an extra layer of protecting our end-users accounts. This is the first step of added authentication within our roadmap.

Exchanges